Key Financial Data Of Reporting Company

D.Western Therapeutics Institute, Inc. - Filing #7727473

Concept 2017-01-01 to
2017-12-31
2017-01-01 to
2017-12-31
As at
2017-12-31
As at
2017-12-31
2016-01-01 to
2016-12-31
2016-01-01 to
2016-12-31
As at
2016-12-31
As at
2016-12-31
2015-01-01 to
2015-12-31
2015-01-01 to
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2014-12-31
2014-01-01 to
2014-12-31
2014-01-01 to
2014-12-31
As at
2014-12-31
As at
2013-12-31
As at
2013-12-31
2013-01-01 to
2013-12-31
2013-01-01 to
2013-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
245,673,000 JPY
254,028,000 JPY
168,002,000 JPY
147,142,000 JPY
61,818,000 JPY
61,818,000 JPY
80,025,000 JPY
JPY
80,000,000 JPY
JPY
Ordinary profit (loss)
-557,934,000 JPY
-668,904,000 JPY
-304,463,000 JPY
-173,541,000 JPY
-282,097,000 JPY
-295,372,000 JPY
-191,685,000 JPY
JPY
-221,214,000 JPY
JPY
Profit (loss)
-1,496,103,000 JPY
-174,770,000 JPY
-283,196,000 JPY
-192,642,000 JPY
-222,171,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
3,365,279,000 JPY
2,945,154,000 JPY
2,400,024,000 JPY
2,366,684,000 JPY
2,347,997,000 JPY
Total number of issued shares
26,258,400 xbrli:shares
24,758,400 xbrli:shares
22,958,400 xbrli:shares
22,768,400 xbrli:shares
22,695,900 xbrli:shares
Net assets
2,095,869,000 JPY
2,160,999,000 JPY
2,830,810,000 JPY
2,877,260,000 JPY
1,930,081,000 JPY
2,112,783,000 JPY
JPY
2,116,222,000 JPY
2,269,440,000 JPY
JPY
Total assets
2,877,489,000 JPY
2,935,773,000 JPY
2,857,218,000 JPY
2,912,795,000 JPY
1,951,221,000 JPY
2,140,035,000 JPY
JPY
2,135,689,000 JPY
2,292,033,000 JPY
JPY
Net assets per share
76.14
82.23
113.71
109.96
82.75
83.49
92.95
99.99
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-57.31
-59.89
-10.46
-7.21
-12.41
-12.99
-8.47
-10.49
Diluted earnings per share
Equity-to-asset ratio
0.695 xbrli:pure
0.736 xbrli:pure
0.985 xbrli:pure
0.935 xbrli:pure
0.974 xbrli:pure
0.881 xbrli:pure
xbrli:pure
0.991 xbrli:pure
0.990 xbrli:pure
xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
JPY
-797,215,000 JPY
-333,558,000 JPY
JPY
JPY
-322,675,000 JPY
-223,527,000 JPY
JPY
-199,750,000 JPY
JPY
Net cash provided by (used in) investing activities
JPY
-763,123,000 JPY
-230,797,000 JPY
JPY
JPY
834,584,000 JPY
286,502,000 JPY
JPY
-1,002,991,000 JPY
JPY
Net cash provided by (used in) financing activities
JPY
1,406,969,000 JPY
1,066,537,000 JPY
JPY
JPY
87,912,000 JPY
36,961,000 JPY
JPY
2,026,131,000 JPY
JPY
Cash and cash equivalents
2,132,677,000 JPY
JPY
JPY
2,291,934,000 JPY
JPY
1,767,157,000 JPY
JPY
1,167,335,000 JPY
1,067,316,000 JPY
JPY
Number of employees
15 xbrli:pure
14 xbrli:pure
12 xbrli:pure
16 xbrli:pure
13 xbrli:pure
15 xbrli:pure
xbrli:pure
13 xbrli:pure
13 xbrli:pure
xbrli:pure
Average number of temporary employees
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.